Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/29/2013US8569358 Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters
10/29/2013US8569357 Taxane pro-emulsion formulations and methods making and using the same
10/29/2013US8569356 Cyclin dependent kinase inhibitors
10/29/2013US8569355 Pyrone-indole derivatives and process for their preparation
10/29/2013US8569354 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
10/29/2013US8569353 Pyrazole compound
10/29/2013US8569352 Imidazole based LXR modulators
10/29/2013US8569351 Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
10/29/2013US8569350 Anti-mitotic anti-proliferative compounds
10/29/2013US8569349 Therapeutic compounds
10/29/2013US8569348 Compounds, compositions, and methods for preventing metastasis of cancer cells
10/29/2013US8569347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
10/29/2013US8569346 Thiazoline ring compounds as botulinum antagonists
10/29/2013US8569345 Compounds and compositions as LXR modulators
10/29/2013US8569344 N-piperidinyl acetamide derivatives as calcium channel blockers
10/29/2013US8569343 Oligomer-opioid agonist conjugates
10/29/2013US8569342 Diastereomers of 4-aryloxy-3-hydroxypiperidines
10/29/2013US8569341 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
10/29/2013US8569340 AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569338 Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds
10/29/2013US8569337 Tri-cyclic pyrazolopyridine kinase inhibitors
10/29/2013US8569336 Compounds for the treatment of inflammatory disorders
10/29/2013US8569335 Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
10/29/2013US8569334 P2X7R antagonists and their use
10/29/2013US8569333 Compounds and methods for treatment and prevention of diseases
10/29/2013US8569332 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/29/2013US8569331 Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds
10/29/2013US8569330 Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
10/29/2013US8569329 Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
10/29/2013US8569328 Compositions and methods comprising tilidine or related compounds and dextromethorphan
10/29/2013US8569327 Phenanthroindolizidine derivative and NFκB inhibitor containing same as active ingredient
10/29/2013US8569326 Forms of rifaximin and uses thereof
10/29/2013US8569325 Method of treatment with coadministration of aspirin and prasugrel
10/29/2013US8569324 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
10/29/2013US8569322 Lamivudine oxalate and preparation method thereof
10/29/2013US8569321 Phosphonate ester derivatives and methods of synthesis thereof
10/29/2013US8569320 Topical composition for the treatment of actinic keratosis
10/29/2013US8569319 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
10/29/2013US8569318 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569316 Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
10/29/2013US8569314 Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD
10/29/2013US8569313 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
10/29/2013US8569312 Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
10/29/2013US8569311 Pyridyl piperidine orexin receptor antagonists
10/29/2013US8569309 4′-demethylepipodophyllotoxin derivative, preparation method and use thereof
10/29/2013US8569308 Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
10/29/2013US8569307 Indole compounds as an inhibitor of cellular necrosis
10/29/2013US8569306 JNK modulators
10/29/2013US8569305 Treatment of tuberous sclerosis associated neoplasms
10/29/2013US8569304 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
10/29/2013US8569303 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
10/29/2013US8569302 Inhibitors of flaviviridae viruses
10/29/2013US8569301 6, 6-dioxo-6-thia-1, 4-diaza-naphthalenes as herbicides
10/29/2013US8569300 Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease
10/29/2013US8569299 Prolylcarboxypeptidase inhibitors
10/29/2013US8569298 Pyridine compounds
10/29/2013US8569297 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
10/29/2013US8569296 PI3K (delta) selective inhibitors
10/29/2013US8569295 Bicyclic urea compounds
10/29/2013US8569294 2-(cyclic amino)-pyrimidone derivatives
10/29/2013US8569292 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
10/29/2013US8569291 Bicyclic dihydroimidazolone CGRP receptor antagonists
10/29/2013US8569289 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
10/29/2013US8569288 Thienotriazolodiazepine derivatives active on apo A
10/29/2013US8569287 Azepino[4,5-B]indoles and methods of use
10/29/2013US8569285 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
10/29/2013US8569284 Inhibitors of the influenza A virus M2 proton channel
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/29/2013US8569282 Carboxamide compounds and their use
10/29/2013US8569281 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK
10/29/2013US8569280 Methods for the treatment of multiple myeloma
10/29/2013US8569279 Method for modulating claudin mediated functions
10/29/2013US8569278 Anti-histamine compositions and use thereof
10/29/2013US8569277 Methods of treating a subject for a condition
10/29/2013US8569276 Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
10/29/2013US8569275 Steroids having 7-oxgen and 17-heteroaryl substitution
10/29/2013US8569274 Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
10/29/2013US8569273 Ophthalmic formulations of cetirizine and methods of use
10/29/2013US8569272 Methods for treating a posterior segment of an eye
10/29/2013US8569271 Compositions comprising tramadol and celecoxib in the treatment of pain
10/29/2013US8569270 Diphenyl sulfide derivatives and medicines containing same as active ingredient
10/29/2013US8569269 Chirally correct retinal cyclodextrin hemiacetals for treating skin disorder
10/29/2013US8569268 Acrylate/methacrylate-based diblock copolymer/anthranilic diamide compositions for propagule coating
10/29/2013US8569267 Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain
10/29/2013US8569265 Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof
10/29/2013US8569264 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
10/29/2013US8569263 Method of producing silane-modified cationized cellulose
10/29/2013US8569262 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
10/29/2013US8569261 Vascular protecting agent having salt-absorption inhibitory activity
10/29/2013US8569260 N-pyrazole A2A receptor agonists
10/29/2013US8569259 Adenosine analogs and their use
10/29/2013US8569254 Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
10/29/2013US8569250 Organic compounds
10/29/2013US8569249 Method for inhibiting activation of macrophages
10/29/2013US8569248 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
10/29/2013US8569247 Hydrolysate of crocin
10/29/2013US8569210 Turfgrass fungicide formulation with pigment
10/29/2013US8569058 Nerve regeneration promoters
1 ... 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 ... 7860